Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asha Cellulose is a prominent Indian manufacturer of cellulose derivatives, primarily serving the pharmaceutical, food, and personal care sectors. The company specializes in the production of high-quality Ethyl Cellulose (EC) and Hydroxypropyl Methylcellulose (HPMC), which are critical excipients used in controlled-release drug delivery, tablet binding, and film coating. Operating out of Gujarat, Asha Cellulose adheres to international quality standards such as USP, EP, and JP to ensure their products meet the rigorous requirements of global pharmaceutical formulation. Their business model focuses on providing reliable, high-purity polymers that enhance the stability and delivery profiles of oral solid dosage forms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ASHA Cellulose.